Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial.

IF 1.3 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Journal of Integrative and Complementary Medicine Pub Date : 2024-09-18 DOI:10.1089/jicm.2024.0184
Cecile A Lengacher,Richard R Reich,Carmen S Rodriguez,Anh Thy Nguyen,Jong Y Park,Hongdao Meng,Sara Tinsley,Gizem Hueluer,Kristine A Donovan,Manolete S Moscoso,Elizabeth Bornstein,John Kiluk,Sreenidhi Nidamanur,Lynne S Padgett,Jean M Lucas,Tamela Fonseca,Anisha Joshi,Katherine J Lin,Matthew Goodman,Kevin E Kip
{"title":"Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial.","authors":"Cecile A Lengacher,Richard R Reich,Carmen S Rodriguez,Anh Thy Nguyen,Jong Y Park,Hongdao Meng,Sara Tinsley,Gizem Hueluer,Kristine A Donovan,Manolete S Moscoso,Elizabeth Bornstein,John Kiluk,Sreenidhi Nidamanur,Lynne S Padgett,Jean M Lucas,Tamela Fonseca,Anisha Joshi,Katherine J Lin,Matthew Goodman,Kevin E Kip","doi":"10.1089/jicm.2024.0184","DOIUrl":null,"url":null,"abstract":"Introduction: The Mindfulness-Based Stress Reduction (MBSR) Program for breast cancer survivors (BCS) is designed to enhance cognitive training through formal and informal meditational practices. This randomized clinical trial (RCT) aimed to evaluate if BCS assigned to either the MBSR(BC), Breast Cancer Education Support (BCES), or Usual Care (UC) regimens experienced greater improvements at 6, 12, and 26 weeks on objective and subjective cognitive performance. Methods: BCS (n = 212) randomized to a three-group RCT: MBSR(BC) (n = 91), BCES (n = 90), or UC (n = 31) were assessed on cognitive performance and symptoms at baseline, 6, 12, and 26 weeks. Linear mixed models were fit to evaluate the effects of the MBSR(BC) program, hypothesizing ordered effect improvements: (MBSR[BC] highest, BCES intermediate, UC lowest) along with baseline characteristics evaluated as moderators. Results: Of the BCS (mean age of 57), 73% were White, and non-Hispanic, and 77% received both chemotherapy (CT) and radiation. Cognitive performance improved in all groups. Although there were no statistically significant between-group differences in cognitive outcomes, significant symptom reductions occurred for the MBSR(BC) group (p = 0.003). Within-group effect size analysis at 26 weeks showed substantial improvements in all three groups (effect sizes >0.50) in subjective impairments and quality of life (effect size >0.50) and objective measures of cognitive performance. MBSR(BC) showed the largest within-group effect size in the reduction of fatigue (effect size = 0.81). Effect sizes occurred in the hypothesized direction for 10 of the 18 outcomes. Discussion: Although the MBSR(BC) program did not show significant differences in cognitive performance compared with BCES and UC, all groups improved and reductions in fatigue were beneficial for MBSR(BC). Results suggest that cognitive performance may improve after CT over time considering one's natural history. Furthermore, BCS enrolled in RCTs may be more motivated to improve their health status (NCT02786797).","PeriodicalId":29734,"journal":{"name":"Journal of Integrative and Complementary Medicine","volume":"65 1","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative and Complementary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/jicm.2024.0184","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The Mindfulness-Based Stress Reduction (MBSR) Program for breast cancer survivors (BCS) is designed to enhance cognitive training through formal and informal meditational practices. This randomized clinical trial (RCT) aimed to evaluate if BCS assigned to either the MBSR(BC), Breast Cancer Education Support (BCES), or Usual Care (UC) regimens experienced greater improvements at 6, 12, and 26 weeks on objective and subjective cognitive performance. Methods: BCS (n = 212) randomized to a three-group RCT: MBSR(BC) (n = 91), BCES (n = 90), or UC (n = 31) were assessed on cognitive performance and symptoms at baseline, 6, 12, and 26 weeks. Linear mixed models were fit to evaluate the effects of the MBSR(BC) program, hypothesizing ordered effect improvements: (MBSR[BC] highest, BCES intermediate, UC lowest) along with baseline characteristics evaluated as moderators. Results: Of the BCS (mean age of 57), 73% were White, and non-Hispanic, and 77% received both chemotherapy (CT) and radiation. Cognitive performance improved in all groups. Although there were no statistically significant between-group differences in cognitive outcomes, significant symptom reductions occurred for the MBSR(BC) group (p = 0.003). Within-group effect size analysis at 26 weeks showed substantial improvements in all three groups (effect sizes >0.50) in subjective impairments and quality of life (effect size >0.50) and objective measures of cognitive performance. MBSR(BC) showed the largest within-group effect size in the reduction of fatigue (effect size = 0.81). Effect sizes occurred in the hypothesized direction for 10 of the 18 outcomes. Discussion: Although the MBSR(BC) program did not show significant differences in cognitive performance compared with BCES and UC, all groups improved and reductions in fatigue were beneficial for MBSR(BC). Results suggest that cognitive performance may improve after CT over time considering one's natural history. Furthermore, BCS enrolled in RCTs may be more motivated to improve their health status (NCT02786797).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于正念的乳腺癌减压疗法(MBSR(BC))治疗癌症相关认知障碍(CRCI)的疗效:随机对照试验》。
简介针对乳腺癌幸存者(BCS)的正念减压(MBSR)计划旨在通过正式和非正式的冥想练习来加强认知训练。这项随机临床试验(RCT)旨在评估被分配到 MBSR(BC)、乳腺癌教育支持(BCES)或通常护理(UC)方案中的乳腺癌幸存者在 6、12 和 26 周后的客观和主观认知表现是否会有更大的改善。研究方法随机参加三组 RCT:MBSR(BC)(n = 91)、BCES(n = 90)或 UC(n = 31)的 BCS(n = 212)在基线、6、12 和 26 周时接受认知表现和症状评估。通过拟合线性混合模型来评估 MBSR(BC)项目的效果,并假设效果的改善是有序的:(MBSR[BC]最高,BCES中等,UC最低),并将基线特征作为调节因素进行评估。结果:在 BCS(平均年龄 57 岁)中,73% 为白人,非西班牙裔,77% 同时接受了化疗(CT)和放疗。所有组别的认知能力都有所提高。虽然认知结果在组间差异上没有统计学意义,但 MBSR(BC)组的症状明显减轻(p = 0.003)。26 周时的组内效应大小分析表明,所有三组在主观障碍和生活质量(效应大小大于 0.50)以及认知能力的客观测量方面均有大幅改善(效应大小大于 0.50)。MBSR(BC)在减少疲劳方面显示出最大的组内效应大小(效应大小 = 0.81)。在 18 项结果中,有 10 项的效应大小与假设方向一致。讨论:虽然与 BCES 和 UC 相比,MBSR(BC)项目在认知能力方面没有显示出显著差异,但所有组别都有所改善,疲劳的减少对 MBSR(BC)有益。结果表明,考虑到个人的自然病史,CT 后认知能力可能会随着时间的推移而得到改善。此外,参加 RCT 的 BCS 可能更有动力改善自己的健康状况(NCT02786797)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
0
期刊最新文献
Biofield Therapies Clinical Research Landscape: A Scoping Review and Interactive Evidence Map. Research in Integrative and Complementary Medicine: Particularities, Challenges, Obstacles, and Misunderstandings. Part 2: Things Can also Work Differently when the Context is Different. Integration of Traditional, Complementary, and Integrative Medicine in the Institutionalization of Evidence-Informed Decision-Making: The World Health Organization Meeting Report. Instruments for Evaluating Undergraduate Medical Education in Complementary and Integrative Medicine: A Systematic Review. Australian Naturopaths Approach to the Clinical Management of Patients Presenting with Sleep Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1